Stamford, CT -- (SBWIRE) -- 09/18/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Affymax, Inc. (OTCMKTS:AFFY), Applied DNA Sciences Inc (OTCBB:APDN), MART RESOURCES INC (OTCMKTS:MAUXF), Cannabis Science Inc (OTCMKTS:CBIS)
Affymax, Inc. (OTCMKTS:AFFY) experienced a plunge of -2.03%, to a market valuation of $54.36 million per share for the previous trading session. After opening the day at $1.48 per share, volume surged to 479,848, leaving behind its daily average volume of 909,191 shares. Beta value for the Company stands at 1.47, indicating its risk level. The stock remained in the $1.44 to $1.52 price range during the session.
Company’s graphical value indicates these stories about the stocks: During the last 5 trades the stock jumped almost +20.83%. During the last one month it rose with the percentage of +20.83. Its year to date performance remained adverse -92.36%. Affymax, Inc., a biopharmaceutical company, engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life-threatening illnesses.
Has AFFY Found The Bottom and Ready To Move Up? Find Out Here
Applied DNA Sciences Inc (OTCBB:APDN) opened its shares at the price of $0.12 for the day, its closing price was $0.119 after losing -0.34% for the day. The company traded with the total volume of 1.71 million shares, while its average trading volume remained 3.06 million shares. The beta of APDN stands at 1.52.
If we review the company’s graph to check its previous trends, we come to know these figures: During the last 5 trades the stock plummeted almost -5.42%. During the last one month it slipped with the percentage of -9.81. Along with these, its year to date performance remained adverse -43.52%. Applied DNA Sciences, Inc. provides botanical-DNA based security and authentication solutions in Europe and the United States. The company offers SigNature DNA markers for embedding into a range of products, including various inks, dyes, textile treatments, thermal ribbon, thread, varnishes, and adhesives.
Has APDN Found The Bottom And Ready To Gain Momentum? Find Out Here
MART RESOURCES INC (OTCMKTS:MAUXF) percentage change mounted/reduced -9.57%, to close at $1.23 with the total traded volume of 271,180 shares, more than average volume of 72,769.
Company’s year to date performance declining as it lost almost -28.49%. If we look at the last 6 months of trade, that is in the bearish zone with a drop of -37.92%.
The 52-week price range of the stock remained $1.20 - $2.27, while during last trade its minimum price was $1.20 and it gained its highest price of $1.35. Mart Resources, Inc., an international upstream oil and gas company, engages in the exploration, development, and production of oil and gas in the Federal Republic of Nigeria.
Why Should Investors Buy MAUXF After the Recent Fall? Just Go Here and Find Out
Cannabis Science Inc (OTCMKTS:CBIS) remained among the day gainers and traded with volume of 1.98 million shares in the last session, as compared to average volume of 2.92 million shares.
CBIS was a loser in the 5 days activity and slipped about -2.11%. The one month performance of the stock was negative and it plunged more than -3.13%.
Its day's lowest price was $0.05 and its hit its day's highest price at $005. CBIS’s total market capitalization is $33.03 million along with 71.42 million shares outstanding. Cannabis Science, Inc., a development stage company, engages in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products. It primarily focuses on developing medications to treat autism, blood pressure, cancer and cancer side effects, HIV, and other illnesses, including general health maintenance.
Why Should Investors Buy CBIS After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)